Rajendra Badgaiyan

Rajendra Badgaiyan's AcademicInfluence.com Rankings

Rajendra Badgaiyan

Biology

#12201

World Rank

#15662

Historical Rank

Neuroscience

#2031

World Rank

#2087

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Rajendra Badgaiyan Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor Rajendra D Badgaiyan is an Indian-American psychiatrist and cognitive neuroscientist. He is best known for developing a new neuroimaging technique for detection of acute changes in concentration of dopamine released in the live human brain during performance of a cognitive. behavioral or emotional task.

(See a Problem?)

Rajendra Badgaiyan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dissociation of response conflict, attentional selection, and expectancy with functional magnetic resonance imaging. (2000) (400)
Mapping the Cingulate Cortex in Response Selection and Monitoring (1998) (207)
A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems (2003) (127)
Striatal dopamine release in sequential learning (2007) (105)
Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems. (2018) (100)
Time Course of Cortical Activations in Implicit and Explicit Recall (1997) (99)
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence. (2018) (96)
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction (2015) (96)
Auditory Priming within and across Modalities: Evidence from Positron Emission Tomography (1999) (96)
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z (2017) (95)
Neuroimaging of Priming: New Perspectives on Implicit and Explicit Memory (2001) (94)
Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. (2017) (88)
Priming within and across Modalities: Exploring the Nature of rCBF Increases and Decreases (2001) (76)
Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat. (2005) (74)
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape (2016) (70)
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery (2015) (69)
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone (2018) (67)
Dopamine release during human emotional processing (2009) (67)
Visual word stem completion priming within and across modalities: a PET study. (1999) (66)
Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial. (2016) (66)
Executive control, willed actions, and nonconscious processing (2000) (66)
Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder (2015) (65)
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS) (2017) (63)
The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD). (2018) (61)
GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™): LESSONS LEARNED FROM AMERICA. (2017) (61)
Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term (2016) (57)
Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis (2018) (57)
Dopamine is released in the striatum during human emotional processing (2010) (55)
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis. (2018) (54)
Genetic Addiction Risk Score (GARS™) as a Predictor of Substance Use Disorder: Identifying Predisposition Not Diagnosis. (2018) (54)
Theory of mind and schizophrenia (2009) (54)
Neuroanatomical organization of perceptual memory: An fMRI study of picture priming (2000) (53)
Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic. (2018) (53)
Striatal dopamine release during unrewarded motor task in human volunteers (2003) (53)
Introducing "Precision Addiction Management (PAM®)" as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America. (2018) (52)
Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulation. (2015) (50)
Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors (2018) (48)
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD). (2017) (48)
The effects of residential dual diagnosis treatment on alcohol abuse (2017) (41)
Retrieval of Relational Information: A Role for the Left Inferior Prefrontal Cortex (2002) (40)
Explicit motor memory activates the striatal dopamine system (2008) (39)
NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity (2015) (36)
The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. (2017) (35)
Co-occurrences of substance use and other potentially addictive behaviors: Epidemiological results from the Psychological and Genetic Factors of the Addictive Behaviors (PGA) Study (2020) (35)
Evidence of Dopaminergic Processing of Executive Inhibition (2011) (33)
Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? (2015) (32)
Topical application of dynorphin A (1–17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury (2002) (32)
Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis (2020) (32)
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair. (2019) (32)
Intracerebral administration of neuronal nitric oxide synthase antiserum attenuates traumatic brain injury-induced blood-brain barrier permeability, brain edema formation, and sensory motor disturbances in the rat. (2006) (30)
Imaging dopamine neurotransmission in live human brain. (2014) (30)
KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit? (2016) (29)
Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence (2013) (28)
THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS. (2016) (27)
An L-type calcium channel blocker, nimodipine influences trauma induced spinal cord conduction and axonal injury in the rat. (2003) (26)
Conscious awareness of retrieval: an exploration of the cortical connectivity. (2005) (26)
Priming reduces input activity in right posterior cortex during stem completion (1996) (24)
Growth hormone attenuates alterations in spinal cord evoked potentials and cell injury following trauma to the rat spinal cord (2000) (24)
Substance use disorder a bio-directional subset of reward deficiency syndrome. (2017) (23)
Detection of dopamine neurotransmission in “real time” (2013) (23)
Neurotrophic factors attenuate alterations in spinal cord evoked potentials and edema formation following trauma to the rat spinal cord. (2000) (23)
A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry. (2015) (23)
Neurotransmitter imaging: Basic concepts and future perspectives (2011) (22)
Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. (2014) (19)
Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case. (2016) (19)
The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer’s in Aging African-Americans (2018) (18)
Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs (2017) (17)
Addiction Treatment in America: After Money or Aftercare? (2015) (17)
Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms (2015) (17)
Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS) (2017) (16)
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing. (2020) (16)
Complex Singular Value Decomposition Based Noise Reduction of Dynamic PET Images (2011) (16)
Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment? (2016) (16)
Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (16)
Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction (2015) (15)
Nonconscious perception, conscious awareness and attention (2012) (15)
Death by Opioids: Are there non-addictive scientific solutions? (2019) (15)
Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword? (2020) (15)
High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial (2021) (15)
Suprachiasmatic injection of a vasopressin antagonist modifies the circadian rhythm of food intake. (1987) (14)
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse. (2018) (14)
Spinal cord evoked potentials and edema in the pathophysiology of rat spinal cord injury (2005) (14)
“Dopamine homeostasis” requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America’s drug epidemic (2017) (14)
Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD (2018) (14)
Priming of new associations: a PET study (2003) (13)
A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration (2021) (13)
Our evolved unique pleasure circuit makes humans different from apes: Reconsideration of data derived from animal studies (2018) (12)
Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic (2016) (11)
Lithium chloride SCN injection alters the circadian rhythm of food intake. (1989) (11)
A Novel Perspective on Dopaminergic Processing of Human Addiction. (2013) (11)
Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. (2016) (11)
Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality (2015) (10)
Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause. (2017) (10)
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission (2017) (10)
Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29) (2022) (10)
Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce “Dopamine Homeostasis” and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence (2016) (9)
Cortical activation elicited by unrecognized stimuli (2006) (9)
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions (2021) (9)
Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual (2020) (9)
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”? (2022) (8)
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients (2015) (8)
Diet and companionship modulate pain via a serotonergic mechanism (2021) (8)
Neuroprotective Effects of Nitric Oxide Synthase Inhibitors in Spinal Cord Injury‐Induced Pathophysiology and Motor Functions (2005) (8)
Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function. (2014) (8)
Physical Exercise Interventions for Drug Addictive Disorders (2017) (8)
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake (2016) (8)
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development. (2021) (8)
The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population. (2018) (7)
Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone? (2017) (7)
Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? (2015) (7)
Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS). (2014) (6)
Global Evidence for the Key Role of the Dopamine D2 Receptor Gene (DRD2) and DRD2 Receptors in Alcoholism (2017) (6)
Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration. (2020) (6)
Functional imaging of neurotransmission (2007) (6)
Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility (2015) (6)
Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency (2020) (6)
Neurotransmitter imaging: Current status and challenges (2011) (6)
Neuroimaging of priming (2001) (5)
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors (2022) (5)
Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (5)
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management” (2021) (5)
Neurobiology and Spirituality in Addiction Recovery. (2021) (5)
Influence of intracerebroventricularly infused anions on feeding response (1986) (5)
Retraction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (5)
Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling. (2021) (4)
Intracerebroventricular chloride infusion enhances water intake in rats (1987) (4)
Release of striatal dopamine during response inhibition (2011) (4)
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality? (2021) (4)
Editorial [Hot topic: Neurotransmitter Imaging: Current Status and Challenges (Guest Editors: Rajendra D. Badgaiyan)] (2011) (4)
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction? (2021) (4)
Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely (2015) (4)
Nonconscious processing and a novel target for schizophrenia research. (2012) (4)
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors (2022) (4)
Alterations of ventricular pH alter water intake and food consumption in rats (1990) (4)
Should We Embrace Vaccines for Treating Substance- Related Disorder, A Subset of Reward Deficiency Syndrome (RDS)? (2015) (4)
Critical Analysis of White House Anti-Drug Plan (2017) (4)
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects (2022) (3)
Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: “Born Bad” (2017) (3)
Nonconscious processing, anterior cingulate, and catatonia (2002) (3)
Overcoming reward deficiency syndrome by the induction of “dopamine homeostasis” instead of opioids for addiction: illusion or reality? (2022) (3)
A developmental functional MRI study of cortical activation during a spatial working memory task (1997) (3)
Hemineglect (2019) (3)
Induction of homeostatic biological parameters in reward deficiency as a function of an iron-free multi-nutrient complex: Promoting hemoglobinization, aerobic metabolism, viral immuno-competence, and neuroinflammatory regulation (2020) (3)
Third ventricular chloride infusions enhance drinking in water deprived rats (1989) (3)
Neurogenetic and Epigenetic Aspects of Cannabinoids (2022) (3)
Hypothesizing High Negative Emotionality as a Function of Genetic Addiction Risk Severity (GARS) Testing in Alcohol Use Disorder (AUD) (2020) (3)
Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220). (2021) (3)
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry? (2022) (3)
Addiction Research and Therapy in the 21st Century: Providing a Forum for Evidence -Based Addiction Medicine (2013) (3)
Reward Deficiency Syndrome (RDS): Entering the Genomics and Neuroscience Era of Addiction Medicine (2015) (2)
Activation of the Central Serotonergic System Reduces Hyperalgesia in Sickle Mice (2016) (2)
Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression. (2021) (2)
Buprenorphine and Naloxone Combinations and Dopamine (2018) (2)
Coupling Neurogenetics ( GARS TM ) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome ( RDS ) : Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms Journal of Reward Deficiency Syndrome (2016) (2)
Priming of new associations (2003) (2)
A linear model for characterizing neurotransmitter release dynamics from PET data (2007) (2)
Translational and Molecular Cytoarchitectural Genetic Guided Therapy to Induce Dopamine Homeostatic Neuro-signaling in Reward Deficiency and Associated Drug and Behavioral Addiction Seeking: A 60 Year Sojourn the Future is Now. (2021) (2)
Calvin klein (CK) designer cocktail, new “Speedball” is the “grimm reaper”: Brain dopaminergic surge a potential death sentence (2020) (2)
Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation (2022) (2)
Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence? (2022) (2)
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse? (2019) (2)
A linear simplification of the parametric ntPET model for estimation of neurotransmitter response kinetics (2009) (2)
Neuroquantum Theories of Psychiatric Genetics: Can Physical Forces Induce Epigenetic Influence on Future Genomes? (2015) (2)
Striatal dopamine release during emotional memory processing (2007) (2)
Detection of task-induced release of extrastriatal dopamine using fallypride (2007) (2)
Hypothesizing Molecular Genetics of the Holocaust: Were Dopaminergic Genes Involved or Brain Wash? (2016) (1)
Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise (2021) (1)
Reward Deficiency Solution System (RDS): A Tale of Three Scientists (2014) (1)
Bariatric surgery: Potential post-operative heightened sensitivity to substances or behaviors (2021) (1)
Dipsogenic and feeding influences of intraventricularly infused anionic choline solutions (1991) (1)
Conscious Awareness and the Brain Processing. (2005) (1)
Correction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (1)
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic. (2021) (1)
Embracing Reward Deficiency Syndrome (RDS) Solution System: A Genomic Thrust (2015) (1)
Dietary Pattern of Lactating Women in an Urban Community (1993) (1)
Invited Commentary: In a Genomic Era, Should We Promote Dopamine Homeostasis to Treat Opiate/ Opioid Abuse, Instead of Blocking Brain Dopamine Function? (2017) (1)
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids (2022) (1)
Manipulation of the extrastriate frontal loop can resolve visual disability in blindsight patients. (2012) (1)
Hypothesizing Major Depression as a Subset of Reward Deficiency Syndrome (RDS) Linked to Polymorphic Reward Genes: Considerations for Translational Medicine Approaches for Future Drug Development (2019) (1)
Understanding that Addiction Is a Brain Disorder Offers Help and Hope (2022) (1)
Proposing FDA consideration for the treatment and prophylaxis of opioid and psychostimulant abuse to incorporate the induction of DNA guided dopamine homeostasis: Anti-reward deficiency restoration solution (ARDS) (2020) (1)
Attenuation of Regional Cerebral Blood Flow During Memory Processing After Coronary Artery Bypass Surgery (2014) (1)
Opioid and dopamine genes interact to predict precision naltrexone response in alcohol use disorder: Interpretation misfires (2021) (1)
Why haven't we solved the addiction crisis? (2022) (1)
Hypnosis (2019) (0)
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia (2020) (0)
Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases. (2022) (0)
Imaging dopamine neurotransmission in live human brain 7 (2014) (0)
Complex singular value decomposition improves parameter estimation in dynamic PET images (2011) (0)
Author ' s personal copy Dopamine release during human emotional processing (2009) (0)
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family (2022) (0)
Precision Behavioral Management (PBM) A Novel Approach to Combat Post-Traumatic Stress Disorder (PTSD). (2018) (0)
Historical perspective (2019) (0)
Using “ Genetic Precision Medicine ” to Treat and Prevent Obesity : Induction of “ Dopamine Homeostasis ” (2017) (0)
Offering a putative neurobiological “dopamine homeostatic” solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of “precision behavioral management” (2022) (0)
Blindsight (2019) (0)
Dopaminergic neuroimaging across the brain (2013) (0)
Coupling Genetic Addiction Risk Score (GARS) and (2017) (0)
Attention (2019) (0)
Dopaminergic processing of nonconscious memory (2012) (0)
Detection of Acute Changes in Neurotransmission in the Live Human Brain (2016) (0)
Proceedings of the 2 nd International Conference on Addiction Medicine and Reward Deficiency Syndrome (2017) (0)
The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer’s in Aging African-Americans (2017) (0)
Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index (2022) (0)
Emotion (2019) (0)
Report on the Inaugural Reward Deficiency Syndrome Summit (RDS-1) (2015) (0)
Nondisplaceable compartment Plasma compartment k 4 k 2 Receptor compartment (2011) (0)
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing (2022) (0)
Correction: Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely? (2015) (0)
DOPAMINE NEUROTRANSMISSION IN ADHD (2011) (0)
A Systems Biological Approach Coupling Reward Gene Polymorphisms and aNutraceutical (KB220Z) Pro-Dopamine Regulator (PDR) as Putative“Standard of Care” to Treat Reward Deficiency Syndrome (RDS): EmergingEvidence - Based Scientific Induction of “Dopamine Homeostasis” (2020) (0)
Report on the First International Conference on Medical Imaging and Case Reports (MICR-2018) (2018) (0)
Polygenic and multi locus heritability of alcoholism: Novel therapeutic targets to overcome psychological deficits (2020) (0)
Journal of Cognitive Neuroscience 11:4 (1999) (0)
Reward Deficiency Syndrome (RDS): Is there a Solution? (2014) (0)
Future outlook (2019) (0)
Report on 2nd International Conference on Addiction Medicine and Reward Deficiency Syndrome (ARDS 2017) (2017) (0)
Meet the Editor-in-Chief (2021) (0)
Dissociations of conflict, control, and expectancy with FMRI (2000) (0)
Customized DNA–directed precision nutrition to balance the brain reward circuitry and reduce addictive behaviors (2018) (0)
Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of "Dopamine Homeostasis" as a Futuristic Alternative to Enhance Rehabilitation Instead of Incarceration. (2023) (0)
Mitigation of TDP-43 Proteinopathy in Mouse Models by Oral Administration of a Novel Semi-Synthetic Withanolide Targeting Nuclear Factor-kappaB Signaling (2019) (0)
Prefrontal activation as a function of response set (1997) (0)
Pro-Dopamine Regulator-( KB 220 ) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome ( RDS ) Mini-review (2017) (0)
Using a novel dynamic molecular imaging technique to study addiction (2013) (0)
Cortical activations, psychiatric symptoms, and climacteric women. (2006) (0)
Opposing Roles of Peripherally-Derived γδ T Cells and Tregs in Epilepsy Pathogenesis (2019) (0)
Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine (2022) (0)
Creativity (2019) (0)
Preface (2023) (0)
“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation (2022) (0)
Reward Deficiency Syndrome Model of Addiction Psychiatry: Everywhere, Everything, and All at Once (2022) (0)
Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy—A Case-Series (2023) (0)
Understanding the Importance of Dopaminergic Deficit in Reward Deficiency Syndrome (RDS): Redeeming Joy Overcoming "Darkness" in Recovery (2015) (0)
Dreams (2019) (0)
Psychiatry Research has Moved Past COVID-19 (2022) (0)
Novel use of stem cell technique to study pathophysiology of psychiatric conditions (2015) (0)
Ventral and dorsolateral prefrontal activation as a function of target probability (1997) (0)
Novel neuroimaging technique to study Parkinson′s disease (2017) (0)
Proceedings of the First International Conference on Medical Imaging and Case Reports ( MICR-2018 ) Meeting (2018) (0)
Single Scan Dynamic Molecular Imaging: An Emerging Neuroimaging Technique (2013) (0)
Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization (2019) (0)
Author ' s personal copy Commentary Theory of mind and schizophrenia q (2009) (0)
Neuroimaging in Psychiatry and Neurology: Current Status and Future Directions (2016) (0)
PRBM_A_292958 2115..2134 (2021) (0)
Novel molecular imaging technique to study dementia (2018) (0)
Genetic Addiction Risk Score (GARS®) as a Predictor of Reward Deficiency Syndrome (RDS): Identifying Predisposition Not Diagnosis (2019) (0)
Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs (2016) (0)
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review (2023) (0)
Nonconscious mind: smart or dumb? (2019) (0)
Centrally infused anions alter body temperature in conscious rats (1995) (0)

This paper list is powered by the following services:

Other Resources About Rajendra Badgaiyan

en.wikipedia.org

What Schools Are Affiliated With Rajendra Badgaiyan?

Rajendra Badgaiyan is affiliated with the following schools:

Rajendra Badgaiyan's Academic­Influence.com Rankings